Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency
Clinical trial NCT04442347 · COMPLETED
Trial details
- NCT number
- NCT04442347
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-03
- Primary completion
- 2023-08-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.